Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Mobility decreased, Pain, Pain in extremity, Pyrexia
Clinical narrative: Temperature 100 for 3 days so far; unable to get out of bed; Body aches/ Extremely sharp shooting pain on left sided of head; constant headache; chills; sweats; pain at injection site as well as down the left side of abdomen and unable to get; pain at injection site as well as down the left side of abdomen; eye pain; Lethargy; Dizziness; Migraine; Severe dry eyes; no appetite; Sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 08Oct2021 (Lot number: FF2590) at the age of 43 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "HTN" (ongoing); "high cholesterol" (ongoing); "sulfonamide allergy" (unspecified if ongoing), notes: known allergies: Sulfa; "Depression" (ongoing); "Anxiety" (ongoing); "Increased blood pressure" (ongoing). Concomitant medication(s) included: LAMICTAL taken for depression, anxiety (ongoing); OXCARBAZEPINE taken for depression, anxiety (ongoing); LEXAPRO taken for depression, anxiety (ongoing); BUSPAR taken for depression, anxiety (ongoing); ATORVASTATIN taken for blood cholesterol increased (ongoing); VALSARTAN HCTZ taken for blood pressure increased (ongoing). Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: RL1283, Location of injection: Arm Right, Route of administration: Intramuscular), administration date: 14Jan2021, when the patient was 43 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 2, Batch/Lot No: EL9264, Location of injection: Arm Left, Route of administration: Intramuscular), administration date: 04Feb2021, when the patient was 43 years old, for COVID-19 immunization. The following information was reported: PYREXIA (non-serious) with onset 09Oct2021 07:30, outcome "recovering", described as "Temperature 100 for 3 days so far"; MOBILITY DECREASED (non-serious) with onset 09Oct2021 07:30, outcome "recovering", described as "unable to get out of bed"; PAIN (non-serious) with onset 09Oct2021 07:30, outcome "recovering", described as "Body aches/ Extremely sharp shooting pain on left sided of head"; HEADACHE (non-serious) with onset 09Oct2021 07:30, outcome "recovering", described as "constant headache"; CHILLS (non-serious) with onset 09Oct2021 07:30, outcome "recovering", described as "chills"; HYPERHIDROSIS (non-serious) with onset 09Oct2021 07:30, outcome "recovering", described as "sweats"; VACCINATION SITE PAIN (non-serious) with onset 09Oct2021 07:30, outcome "recovering", described as "pain at injection site as well as down the left side of abdomen and unable to get"; ABDOMINAL PAIN (non-serious) with onset 09Oct2021 07:30, outcome "recovering", described as "pain at injection site as well as down the left side of abdomen"; EYE PAIN (non-serious) with onset 09Oct2021 07:30, outcome "recovering", described as "eye pain"; PAIN IN EXTREMITY (non-serious) with onset 08Oct2021, outcome "recovering", described as "Sore arm"; LETHARGY (non-serious) with onset 09Oct2021, outcome "recovering", described as "Lethargy"; DIZZINESS (non-serious) with onset 09Oct2021, outcome "recovering", described as "Dizziness"; MIGRAINE (non-serious) with onset 09Oct2021, outcome "recovering", described as "Migraine"; DRY EYE (non-serious) with onset 09Oct2021, outcome "recovering", described as "Severe dry eyes"; DECREASED APPETITE (non-serious) with onset 09Oct2021, outcome "recovering", described as "no appetite". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pyrexia. Therapeutic measures were not taken as a result of mobility decreased, pain, headache, chills, hyperhidrosis, vaccination site pain, abdominal pain, eye pain, pain in extremity, lethargy, dizziness, migraine, dry eye, decreased appetite. Additional information: No Prolonged Hospitalization and no treatment was received. Facility where the most recent COVID-19 vaccine was administered was Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19, Device Date :10Oct2021. It was reported No treatment was required for the event for the initiation of new medication/other treatment/Procedure. Beginning the night of vaccine patient began w/a sore arm of the start of a headache. The following morning 09Oct was unable to get out of bed this continued 10Oct and 11Oct. Patient had a temp of ever 100 degree chills, eye pain, lethargy, dizziness, sweats, pain at the injection site that travelled down the side of the body left side, no appetite, severe dry eyes, migraine. On 12Oct felt better out continued to have a migraine that felt like an extremely sharp shooting pain on the left side of my head that woke me up even night coupled with severe left eye pain. No OTC meds provided any relief (nor did they for the temp - that continued to remain at 100 for 3 days). On 15 Oct was the first day patient woke up to no shooting pain. In addition to the above patient had dry eyes (as if they were covered in sand) with no relief. Patient has never experienced this has subsided as well.  Follow-up attempts are completed. No further information is expected.